NCT00845182View on ClinicalTrials.gov

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Type 2 DiabetesHealthyImpaired Glucose Tolerance
Interventions
DRUG

Pioglitazone

Pioglitazone 15 mg/day for 1 month and then 45 mg/day for 5 months

DRUG

Exenatide

Exenatide 5mcg twice daily for 1 month, then 10mcg twice daily for 5 months

DRUG

Pioglitazone and Exenatide

Pioglitazone 30mg daily for 1 month and then 45mg daily for 5 months and Exenatide 5mcg twice daily for one month then 10mcg twice daily for 5 months

Trial Locations (1)

78229

Barter Research Center, ALM VA Hospital, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00845182 - Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function | Biotech Hunter | Biotech Hunter